In the wake of controversy over a costly overseas stem cell treatment touted by a Winnipeg businessman, the Multiple Sclerosis Society of Canada is launching a genuine clinical trial open to MS patients in Winnipeg and Ottawa. The MS Society has earmarked $4.2 million for the two-year study.
http://ift.tt/1wGdqOu
http://ift.tt/1wGdqOu
No comments:
Post a Comment